Peng Li Selected Research

Peng Li Research Topics

Disease

499	Neoplasms (Cancer) 05/2024 - 03/2002
140	Infections 05/2024 - 04/2003
105	Inflammation (Inflammations) 05/2024 - 04/2006
79	Carcinogenesis 02/2024 - 08/2007
68	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2002
61	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 03/2006
59	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2007
56	Hypoxia (Hypoxemia) 12/2023 - 08/2003
54	Fibrosis (Cirrhosis) 05/2024 - 09/2006
44	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 12/2005
40	Obesity 04/2024 - 01/2007
37	Stomach Neoplasms (Stomach Cancer) 04/2024 - 09/2008
35	Wounds and Injuries (Trauma) 03/2024 - 08/2005
34	Hypertension (High Blood Pressure) 05/2024 - 02/2008
33	Body Weight (Weight, Body) 02/2024 - 06/2006
32	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 02/2008
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2006
32	Reperfusion Injury 02/2024 - 09/2003
29	Insulin Resistance 04/2024 - 10/2007
26	Pain (Aches) 03/2024 - 01/2011
26	Atherosclerosis 10/2023 - 01/2012
25	Carcinoma (Carcinomatosis) 04/2024 - 05/2004
25	Lung Neoplasms (Lung Cancer) 06/2023 - 09/2005
24	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 07/2007
24	Myocardial Infarction 02/2024 - 02/2006
22	Heart Failure 04/2024 - 11/2005
22	Stroke (Strokes) 03/2024 - 07/2007
21	Necrosis 10/2023 - 03/2004
20	Disease Progression 04/2024 - 10/2004
20	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2013
20	Esophageal Squamous Cell Carcinoma 01/2024 - 01/2009
20	COVID-19 01/2024 - 01/2020
19	Colonic Neoplasms (Colon Cancer) 03/2024 - 12/2005
19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2023 - 01/2012
19	Ischemia 01/2023 - 03/2004
18	Sepsis (Septicemia) 12/2024 - 09/2011
18	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2010
18	Cognitive Dysfunction 03/2024 - 02/2016
18	Leukemia 12/2023 - 01/2013
17	Hemorrhage 11/2023 - 09/2003
17	Neuroinflammatory Diseases 09/2023 - 08/2013
15	Thrombosis (Thrombus) 01/2024 - 01/2012
15	Adenocarcinoma 10/2023 - 04/2006
14	Schizophrenia (Dementia Praecox) 04/2024 - 05/2009
14	Parkinson Disease (Parkinson's Disease) 04/2024 - 09/2011
14	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 09/2003
13	Glioma (Gliomas) 05/2024 - 06/2011

Drug/Important Bio-Agent (IBA)

195	Proteins (Proteins, Gene)FDA Link 05/2024 - 09/2002
126	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2003
60	CytokinesIBA 01/2024 - 05/2009
57	MicroRNAs (MicroRNA)IBA 05/2024 - 03/2012
56	Messenger RNA (mRNA)IBA 03/2024 - 09/2002
48	LipidsIBA 12/2023 - 02/2008
40	Glucose (Dextrose)FDA LinkGeneric 12/2024 - 08/2012
38	Long Noncoding RNAIBA 01/2024 - 01/2011
34	Therapeutic UsesIBA 01/2024 - 12/2006
34	Peptides (Polypeptides)IBA 12/2023 - 04/2002
32	RNA (Ribonucleic Acid)IBA 02/2024 - 10/2002
29	AntigensIBA 10/2023 - 08/2006
27	Chimeric Antigen ReceptorsIBA 12/2023 - 01/2016
27	CollagenIBA 08/2023 - 07/2003
26	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 10/2004
26	LigandsIBA 03/2024 - 10/2002
26	EnzymesIBA 01/2024 - 08/2005
25	Phosphotransferases (Kinase)IBA 04/2023 - 12/2009
24	Interleukin-6 (Interleukin 6)IBA 01/2024 - 03/2008
23	AntioxidantsIBA 03/2024 - 02/2006
20	Transcription Factors (Transcription Factor)IBA 03/2024 - 10/2002
20	Circular RNAIBA 01/2024 - 01/2017
19	Caspase 3 (Caspase-3)IBA 04/2024 - 01/2013
19	LipopolysaccharidesIBA 11/2023 - 01/2014
19	Hormones (Hormone)IBA 09/2023 - 08/2004
18	Indicators and Reagents (Reagents)IBA 12/2023 - 11/2007
18	HydrogelsIBA 10/2023 - 04/2011
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023 - 04/2003
17	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 06/2014
17	VaccinesIBA 11/2023 - 05/2006
17	Small Interfering RNA (siRNA)IBA 12/2021 - 11/2011
16	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 03/2010
16	Carrier Proteins (Binding Protein)IBA 03/2024 - 09/2004
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 08/2003
16	CateninsIBA 01/2023 - 04/2015
15	Blood Glucose (Blood Sugar)IBA 12/2024 - 02/2010
15	Insulin (Novolin)FDA Link 10/2022 - 10/2013
15	NF-kappa B (NF-kB)IBA 05/2021 - 09/2003
14	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 04/2010
14	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 01/2015
14	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2017
14	Sirtuin 1IBA 01/2023 - 05/2014
14	Oxygen (Dioxygen)IBA 01/2023 - 01/2011
14	Enterotoxin ReceptorsIBA 11/2013 - 12/2005
13	Triglycerides (Triacylglycerol)IBA 04/2024 - 10/2007

Therapy/Procedure

202	Therapeutics 05/2024 - 04/2002
64	Drug Therapy (Chemotherapy) 04/2024 - 06/2006
44	Immunotherapy 04/2024 - 07/2008
19	Radiotherapy 02/2024 - 05/2004
19	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 12/2013
18	Aftercare (After-Treatment) 04/2024 - 06/2005
18	Transplantation 01/2023 - 11/2008
14	Stents 02/2024 - 07/2012